← Evidence map

ReviewWorld journal of gastroenterology2016

Use of rifaximin in gastrointestinal and liver diseases.

Rani H Shayto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

38 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

NCT04431934437 enrolled2020
Full record →Abstract, authors, funding and every citing paper · PMID 27547007